(216 days)
-Restoration of Class III, Class V, smaller Class IV
-Repair of resin, porcelain, and acrylic temporary materials
-Undercut blockout
The subject device is a light-curved complex resin for aesthetic restoration for both anterior and posterior parts, which is used for restoration that requires aesthetics through decay and damage in a form of paste with unpolymerized dimethacrylate monomer, inorganic filler, and photoinitiators mixed. The subject device is packaged with the following: Syringe, Disposable Tip, Protective Cap, Shade Sheet
Here's a breakdown of the acceptance criteria and the study information for the DiaFil Flow device, based on the provided FDA 510(k) summary:
1. Table of Acceptance Criteria and Reported Device Performance
The FDA 510(k) summary for DiaFil Flow (K192284) primarily demonstrates substantial equivalence through non-clinical performance data and comparison to a predicate device. The "acceptance criteria" are therefore framed around adherence to harmonized standards and showing similar properties to the predicate.
| Acceptance Criteria Category | Specific Criteria/Standard | Reported Device Performance | Comments |
|---|---|---|---|
| Non-Clinical Performance | ISO 4049:2009 (Dentistry - Polymer-based restorative materials) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 7405:2008 (Dentistry – Evaluation of biocompatibility of medical devices used in dentistry) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-1:2009 (Evaluation and testing within a risk management process) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-2:2006 (Animal welfare requirements) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-3:2014 (Tests for genotoxicity, carcinogenicity and reproductive toxicity) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-5:2009 (Tests for in vitro cytotoxicity) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-6:2016 (Tests for local effects after implantation) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-10:2010 (Tests for irritation and skin sensitization) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-11:2017 (Tests for systemic toxicity) | Conformance demonstrated | Subject device conforms to this standard. |
| Non-Clinical Performance | ISO 10993-12:2012 (Sample preparation and reference materials) | Conformance demonstrated | Subject device conforms to this standard. |
| Equivalence to Predicate | Indications for Use | "The subject device has the same indications for use as the predicate device. The indications for use of the subject device is more simplified than the predicate device." | Considered equivalent. |
| Equivalence to Predicate | Main Raw Materials | "The main compositions are similar... DiaFil Flow and the predicate device are substantially equivalent through Biological Safety Assessment Report. (#BSA-2018-14)" | Considered equivalent despite not being exactly the same. |
| Equivalence to Predicate | Mechanical Properties (Curing Time) | 20 seconds (same as predicate) | Considered equivalent. |
| Equivalence to Predicate | Mechanical Properties (Photopolymerization Type Resin) | Light-cured (same as predicate) | Considered equivalent. |
| Equivalence to Predicate | Shelf Life | 3 years (same as predicate) | Considered equivalent. |
| Equivalence to Predicate | Biocompatibility | Biocompatible (same as predicate) | Considered equivalent. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: The document does not specify a distinct "test set" in terms of discrete samples for performance evaluation beyond conformity to standards. The evaluation is primarily based on bench testing against harmonized standards and a comparison to a predicate device. No specific number of items tested for each characteristic (e.g., strength, wear) is provided in the summary.
- Data Provenance: The studies are described as "non-clinical performance data" and "non-clinical bench testing." This implies internal laboratory testing conducted by the manufacturer, DiaDent Group International, located in Cheongju-si, Chungcheongbuk-do, Republic of Korea. The data is retrospective in the sense that it was generated for the 510(k) submission, not as a continuous monitoring process.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts
- The summary does not mention "experts" in the context of establishing ground truth for a test set in the way one might for an AI/device diagnostic study. This is a dental material, and the "ground truth" is established by adherence to the objective criteria laid out in international standards (e.g., ISO for dental materials, ISO 10993 for biocompatibility). There is no mention of human expert consensus or radiologists in this context.
4. Adjudication Method for the Test Set
- No adjudication method is described, as the evaluation is based on objective measurements against harmonized standards, not on subjective interpretations requiring adjudication.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
- No, an MRMC comparative effectiveness study was not done. This type of study (comparing human readers with and without AI assistance) is relevant for diagnostic imaging devices. DiaFil Flow is a dental restorative material, and its evaluation focuses on material properties and biocompatibility, not diagnostic performance.
6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done
- Not applicable/Not done. This device is a physical material, not an algorithm or AI system. Therefore, the concept of "standalone algorithm performance" does not apply. The performance evaluated is the physical and chemical properties of the material itself.
7. Type of Ground Truth Used
- The "ground truth" for the non-clinical performance data is defined by the specifications and acceptable ranges/pass criteria within the referenced harmonized ISO standards (e.g., ISO 4049 for material properties, ISO 10993 series for biocompatibility). These standards define objective, measurable physical, chemical, and biological endpoints. The "Biological Safety Assessment Report (#BSA-2018-14)" also contributed to establishing the safety ground truth.
8. Sample Size for the Training Set
- Not applicable/Not provided. This is not an AI/machine learning device that would require a "training set" in the conventional sense. The "training" for a material like this involves formulation development and manufacturing process controls, not data-driven algorithm training.
9. How the Ground Truth for the Training Set Was Established
- Not applicable. As a dental restorative material, the concept of a "training set" and associated ground truth establishment for a training set does not apply.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo in blue. Underneath the FDA logo is the word "ADMINISTRATION".
March 25, 2020
Diadent Group International Kab Lee Quality Assurance Manager 16, Osongsaengmyeong 4-ro, Osong-eup, Heungdeok-gu Cheongji-si, 28161 Chungcheongbuk-do KOREA
Re: K192284
Trade/Device Name: DiaFil Flow Regulation Number: 21 CFR 872.3690 Regulation Name: Tooth shade resin material Regulatory Class: Class II Product Code: EBF Dated: December 26, 2019 Received: December 26, 2019
Dear Kab Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
{1}------------------------------------------------
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for Srinivas "Nandu" Nandkumar, Ph.D. Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K192284
Device Name DiaFil Flow
Indications for Use (Describe)
-Restoration of Class III, Class V, smaller Class IV
-Repair of resin, porcelain, and acrylic temporary materials
-Undercut blockout
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) Summary
This 510(k) summary on the safety and effectiveness information is submitted in accordance with the requirements of 21 CFR 807.92.
1. Application Information
| Date Prepared | Mar 25,2020 |
|---|---|
| Company Name andAddress | DiaDent Group International16, Osongsaengmyeong 4-ro, Osong-eup, Heungdeok-gu,Cheongju-si, Chungcheongbuk-do, 28161, Republic of Korea |
| Contact Person | Kab Sun LeeQuality Assurance ManagerPhone: +82-43-266-2315FAX: +82-43-235-2315Email: diadent32@diadent.co.kr |
2. Device Information
| Device Name | DiaFil Flow |
|---|---|
| 510(k) Number | K192284 |
| Classification Name | Tooth shade resin material |
| Review Panel | Dental |
| Regulation Number | 21 CFR 872.3690 |
| Product Code | EBF |
| Device Class | II |
3. Predicate Devices
The legally marketed devices to which substantial equivalence is being claimed are:
| Primary Predicate Device | |
|---|---|
| 510(k) Number: | K060637 |
| Applicant: | VERICOM CO., LTD. |
| Device Name: | DENFIL FLOW |
| Regulation Number: | 21 CFR 872.3690 |
| Product Code: | EBF |
| Device Class: | II |
4. Device Description
The subject device is a light-curved complex resin for aesthetic restoration for both anterior and posterior parts, which is used for restoration that requires aesthetics through decay and damage in a form of paste with unpolymerized dimethacrylate monomer, inorganic filler, and photoinitiators mixed. The subject device is packaged with the following: Syringe, Disposable Tip, Protective Cap, Shade Sheet
Model Name: There are 57 models, and they are divided 19 types. (A1, A2, A2O, A3, A3O, A3.5, A4, B1, B2, B3, B4, C1, C2, C3, C4, D1, D2, D3, D4) These 19 types have differences in the pigment type and content (%).
{4}------------------------------------------------
Also, they (19 types) are packaged according to 3 forms: Economic, Refill, Intro Kit. The components of each package form are as follows.
| Components | |||
|---|---|---|---|
| Syringe | Disposable tips | Shade Sheet | |
| Economic Package | 2g x 4ea | 40ea | 1ea |
| Refill Package | 2g x 1ea | 10ea | N/A |
| Intro Kit | 0.5g x 1ea | 2ea | N/A |
5. Indications for Use
-Restoration of Class III. Class V. smaller Class IV
-Repair of resin, porcelain, and acrylic temporary materials
-Undercut blockout
6. Non-Clinical Performance Data
This device has demonstrated conformance with non-clinical performance requirements through evaluation and testing in accordance with the following harmonized standards:
•ISO 4049:2009, Dentistry - Polymer-based restorative materials
•ISO 7405:2008, Dentistry – Evaluation of biocompatibility of medical devices used in dentistry
•ISO 10993-1:2009, Evaluation and testing within a risk management process
•ISO 10993-2:2006, Animal welfare requirements
•ISO 10993-3:2014, Tests for genotoxicity, carcinogenicity and reproductive toxicity
·ISO 10993-5:2009, Tests for in vitro cytotoxicity
•ISO 10993-6:2016, Tests for local effects after implantation
•ISO 10993-10:2010, Tests for irritation and skin sensitization
· ISO 10993-11:2017, Tests for systemic toxicity
·ISO 10993-12:2012, Sample preparation and reference materials
Through this additional non-clinical bench testing, the subject device is substantially equivalent to the predicate device.
7. Clinical Performance Data
No clinical data was collected or provided to support substantial equivalence between the subject and predicate devices.
8. Comparison with predicate Device
8.1 Comparison table
This device compares to the legally marketed devices as follows:
| Subject Device | Primary Predicate Device | Discussion | |
|---|---|---|---|
| 510(k)Number | - | K060637 | |
| Applicant | DiaDent GroupInternational | VERICOM CO., LTD. | |
| Device Name | DiaFil Flow | DENFIL FLOW | |
| Indicationsfor Use | •Restoration of ClassIII, Class V, smallerClass IV | •Class V restorations(Cervical caries, rooterosion, wedgeshaped defects) | See the below |
| Repair of resin, porcelain, and acrylic temporary materials Undercut blockout | Anterior restorations (Class III, IV) Small posterior restorations Restorative therapy for mini-cavities of all types Extended fissures sealings in molars and premolars Repair of composite/ceramic veneers Blocking out of undercuts | ||
| Description | DiaFil Flow belongs to Group 1 of Class 2 of Type 1 according to the standard classification of ISO 4049. It is a light-curved complex resin for aesthetic restoration for both anterior and posterior parts. It is used for aesthetic restoration which is caused by decay and damage, and it is a paste form consisting of a mixture of unpolymerized dimethacrylate monomer, inorganic filler, and photoinitiators. That means that it makes a hard restoration by polymerizing through dental visible-ray polymerizer after recovering with the unpolymerized product. | DenFil Flow is a light-cured radio-opaque flowable restorative resin. It is composed of Epoxyacrylate (Bis-GMA), Diurethane dimethacrylate, Triethylenglycol dimethacrylate, Barium aluminosilicate, and other materials. As Denfil flow has a lower viscosity than paste type composite resin-Flow; 0.16 mm/30sec, so it can restore narrow & deep cavity easily. DenFil Flow can be applied to fill cavities of all types exactly and efficiently by using a disposable tip. And DenFil Flow has various shades that correspond to the most common used shading system. | Equivalent |
| Package Contents | Syringe Disposable Tip Protective Cap | Syringe Disposable Tip Protective Cap | Equivalent |
| Image | Image: DIAFIL FLOW | Image: DenFil Flow | |
| Composition | •UDMA•Bis-EMA•TMPTMA•BKY-405•Barium-alumino-silicate•Silica•Ytterbium•Camphorquinone•Ethyl-4-(Dimethylamino)benzoate(EDB)•BHT•2-Hydoxy-4-(octoxy)benzophenone | •UDMA•Bis-GMA•TEGDMA•Barium-alumino-silicate•Silica | See the below |
| Light curingtime | 20 seconds(If light curing unitoutput is below400mW/cm2, asmeasured by a curingradiometer, more timemay be needed.) | 20 seconds(If light curing unitoutput is below400mW/cm2, asmeasured by a curingradiometer, more timemay be needed.) | Equivalent |
| Period of Use | Permanent | Permanent | Equivalent |
| Shelf life | 3 years | 3 years | Equivalent |
| Bio-compatibility | Biocompatible | Biocompatible | Equivalent |
| Standards | ISO7405 | ISO7405 | Equivalent |
{5}------------------------------------------------
Product Name: DiaFil Flow
{6}------------------------------------------------
DiaDent Group International
Product Name: DiaFil Flow
9. Differences
Indication for use
| Subject Device | Primary Predicate Device |
|---|---|
| DiaFil Flow | DENFIL FLOW |
| Restoration of Class III, Class V,smaller Class IV | Class V restorations (cervical caries, root erosion,wedge shaped defects) |
| Anterior restorations (Class III, IV) | |
| Small posterior restorations | |
| Repair of resin, porcelain, andacrylic temporary materials | Restorative therapy for mini-cavities of all types |
| Extended fissures sealings in molars and premolars | |
| Repair of composite/ceramic veneers | |
| Undercut blockout | Blocking out of undercuts |
{7}------------------------------------------------
The subject device has the same indications for use as the predicate device. The indications for use of the subject device is more simplified than the predicate device.
| Material composition |
|---|
| Subject Device | Primary Predicate Device |
|---|---|
| DiaFil Flow | DENFIL FLOW |
| •UDMA | •UDMA |
| •Bis-EMA | •Bis-GMA |
| •TMPTMA | •TEGDMA |
| •BKY-405 | •Barium-alumino-silicate |
| •Barium-alumino-silicate | •Silica |
| •Silica | |
| •Ytterbium | |
| •Camphorquinone | |
| •Ethyl-4- | |
| (Dimethylamino)benzoate(EDB) | |
| •BHT | |
| •2-Hydoxy-4- | |
| (octoxy)benzophenone |
The main compositions are similar, but the compositions of DiaFil Flow and the predicate device are not same completely. However, DiaFil Flow and the predicate device are substantially equivalent through Biological Safety Assessment Report. (#BSA-2018-14)
The subject device has the similar technological characteristics as the predicate device: indications for use, main raw materials, mechanical properties (curing time, photopolymerization type resin).
ConClusions
Based on the above information and all data provided in this submission, the comparison of indications for use, technological characteristics, and non-clinical performance testing demonstrates that the subject device is substantially equivalent to the legally marketed devices identified in this submission.
§ 872.3690 Tooth shade resin material.
(a)
Identification. Tooth shade resin material is a device composed of materials such as bisphenol-A glycidyl methacrylate (Bis-GMA) intended to restore carious lesions or structural defects in teeth.(b)
Classification. Class II.